(Q27852185)

English

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer

scientific article

Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer

In more languages

Statements

scholarly article

1 reference

PubMed publication ID

13 November 2016

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer (English)

1 reference

PubMed publication ID

13 November 2016

prostate cancer

1 reference

based on heuristic

inferred from title

Shirley Hodgson

29

0 references

Malgorzata Tymrakiewicz

6

object named as

Malgorzata Tymrakiewicz

0 references

Zsofia Kote-Jarai

36

object named as

Zsofia Kote-Jarai

0 references

Daniel Leongamornlert

5

object named as

Daniel Leongamornlert

0 references

object named as

Tokhir Dadaev

8

0 references

Edward Saunders

object named as

Ed Saunders

4

0 references

object named as

Elena Castro

1

0 references

object named as

Rosalind Eeles

37

0 references

object named as

D Gareth Evans

17

0 references

21

object named as

Diana Eccles

0 references

Douglas F. Easton

35

object named as

Douglas F Easton

0 references

15

object named as

Debra Frost

0 references

Antonis C Antoniou

34

object named as

Antonis C Antoniou

0 references

Marc Tischkowitz

18

object named as

Marc Tischkowitz

0 references

author name string

Chee Goh

2

0 references

David Olmos

3

0 references

Nadiya Mahmud

7

0 references

Koveela Govindasami

9

0 references

Michelle Guy

10

0 references

Emma Sawyer

11

0 references

Rosemary Wilkinson

12

0 references

Audrey Ardern-Jones

13

0 references

Steve Ellis

14

0 references

Susan Peock

16

0 references

Trevor Cole

19

0 references

Rosemarie Davidson

20

0 references

Carole Brewer

22

0 references

Fiona Douglas

23

0 references

Mary E Porteous

24

0 references

Alan Donaldson

25

0 references

Huw Dorkins

26

0 references

Louise Izatt

27

0 references

Jackie Cook

28

0 references

M John Kennedy

30

0 references

Lucy E Side

31

0 references

Jacqueline Eason

32

0 references

Alex Murray

33

0 references

language of work or name

0 references

publication date

10 May 2013

0 references

Journal of Clinical Oncology

0 references

31

0 references

14

0 references

1748-57

0 references

Global cancer statistics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

20 March 2017

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

20 March 2017

Mortality results from a randomized prostate-cancer screening trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

20 March 2017

Mendelian inheritance of familial prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

20 March 2017

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

20 March 2017

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

20 March 2017

Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

7 April 2017

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

7 April 2017

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

24 May 2017

Germline BRCA1 mutations increase prostate cancer risk

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

Mortality results from the Göteborg randomised population-based prostate-cancer screening trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

Germline BRCA mutations denote a clinicopathologic subset of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

NCCN clinical practice guidelines in oncology: prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

Rapid progression of prostate cancer in men with a BRCA2 mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

Diagnosis and treatment of prostate cancer: summary of NICE guidance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

Unravelling the genetics of prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

Cancer risks in BRCA2 mutation carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

29 September 2017

Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

27 November 2018

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

27 November 2018

Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

27 November 2018

Prostate Cancer Progression and Survival in BRCA2 Mutation Carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

27 November 2018

A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

27 November 2018

Genetic predisposition to prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

27 November 2018

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3641696

27 November 2018

No difference in survival between sporadic, familial and hereditary prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23569316

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of family history on outcome in German patients treated with radical prostatectomy for clinically localised prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23569316

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics of Patients With Familial Versus Sporadic Prostate Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23569316

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased Prostate Cancer-Specific Survival of Men withBRCA2 Mutations from Multiple Breast Cancer Families

1 reference

https://pubmed.ncbi.nlm.nih.gov/23569316

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27852185&oldid=1790850208"